Nearly one in four American adults lives with chronic pain, and for many dealing with spine and joint conditions, the path forward still tends to narrow to the same few options: medication, physical therapy, or surgery. That gap has fueled growing interest in regenerative medicine, a field built on the idea that the body's own cells, given the right support, can help repair damage conventional treatment isn't designed to reverse. As that interest has grown, and as states like Florida have expanded access to stem cell therapies, a number of companies that have long served American patients abroad are now building capacity closer to home.
RejuvStem is one of them. The regenerative medicine company operates two clinics in Cancun, Mexico, and is preparing to open Auragenesis Labs, Inc., a stem cell manufacturing lab near Miami developed in partnership with Longeveron and expected to open within the next one to two months. The facility will be the company's first manufacturing operation in the United States. Helping lead that expansion is John Merola, RejuvStem's chief operating officer and a partner in the business, who first came to the company the way many of its patients do, looking for an alternative to surgery.
